Adjusting the role of hydroxychloroquine with or without azithromycin in patients with COVID-19
Taking recent publications into account, one should consider avoiding routine use of hydroxychloroquine, especially if combined with azithromycin, for COVID-19. Such treatment may be associated with the increased risk for hospital mortality and QT prolongation, while there is no documented effective...
| Published in: | Качественная клиническая практика |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | Russian |
| Published: |
Izdatelstvo OKI
2020-10-01
|
| Subjects: | |
| Online Access: | https://www.clinvest.ru/jour/article/view/527 |
